drugset / Trial / NCT05369104

Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.

NCT05369104 ↗

Phase 2 Unknown 64 enrolled Phagenix
RandomizedParallel-groupDouble-blindTreatment

Summary

Pilot non comparative study assessing the clinical control of infection of DAIR + SAT +NaCl and DAIR + SAT + Phages anti-Staphylococcus aureus in patients with Staphylococcus aureus Prosthetic Joint Infection with an indication of DAIR + SAT.

Timeline

Start
2022-06-15
Primary completion
2023-12-16
Completion
2025-06-16

Drugs

EvaluationDrugModalityDoseRoute
Subject PP1493 Other / unclassified 1 ml Other
Subject PP1815 Other / unclassified 1 ml Other